ReviewJournal for immunotherapy of cancer2022

Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition.

Meagan-Helen Henderson Berg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.